Average Co-Inventor Count = 3.98
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Duke University (80 from 1,999 patents)
2. Children's Medical Center Corporation (5 from 1,030 patents)
3. University of Pennsylvania (4 from 2,551 patents)
4. University of California (3 from 15,331 patents)
5. Bristol-myers Squibb Compnay (3 from 3,663 patents)
6. The Government of the United States of America As Represented by the Secretary of the Deptartment of Health and Human Services (3 from 3,415 patents)
7. University of North Carolina at Chapel Hill (3 from 1,262 patents)
8. The Uab Research Foundation (3 from 576 patents)
9. US Government As Represented by the Secretary of the Army (2 from 8,677 patents)
10. Leland Stanford Junior University (2 from 5,253 patents)
11. University System of Maryland (2 from 1,912 patents)
12. Boston University (2 from 808 patents)
13. Other (1 from 832,347 patents)
14. New York University (1 from 1,617 patents)
15. Dana-farber-cancer Institute Inc. (1 from 1,192 patents)
81 patents:
1. 12286471 - Inhibitors of complement factor H
2. 12173051 - Bispecific molecules comprising an HIV-1 envelope targeting arm
3. 12138304 - HIV-1 envelope stabilizing mutations
4. 11944681 - HIV-1 neutralizing antibodies and uses thereof
5. 11897946 - Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH
6. 11884704 - Compositions comprising HIV envelopes to induce CH235 lineage antibodies
7. 11814413 - Compositions comprising modified HIV envelopes
8. 11773144 - Mosaic HIV-1 envelopes to induce ADCC responses
9. 11746143 - Methods to identify immunogens by targeting improbable mutations
10. 11421031 - Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
11. 11318197 - Compositions and methods for inducing HIV-1 antibodies
12. 11246920 - Compositions and methods for inducing HIV-1 antibodies
13. 11161895 - Methods to identify immunogens by targeting improbable mutations
14. 11136380 - Anti-complement factor H antibodies
15. 11077130 - Methods for reducing HIV-1 mother-to-child transmission by inducing V3-specific or CD4 binding site-specific antibodies